MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/1352458510375706

Медицинская библиотека · Multiple sclerosis (Houndmills, Basingstoke, England) · 2010

Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis.

Yoshimura Satoshi, Ochi Hirofumi, Isobe Noriko, Matsushita Takuya, Motomura Kyoko, Matsuoka Takeshi, Minohara Motozumi, Kira Jun-ichi

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Within multiple sclerosis lesions, brain-derived neurotrophic factor is detected in neurons and immunocytes.

OBJECTIVE

To clarify brain-derived neurotrophic factor production by peripheral blood immunocytes and its relationship with clinical parameters in multiple sclerosis.

METHODS

Serum brain-derived neurotrophic factor levels were measured by conventional enzyme-linked immunosorbent assay while brain-derived neurotrophic factor production by immunocytes was determined by an in situ enzyme-linked immunosorbent assay in 74 multiple sclerosis patients, 32 healthy controls, and 86 patients with other neurological diseases. The tyrosine kinase receptor TrkB expression level in peripheral blood mononuclear cells was measured by real-time polymerase chain reaction.

RESULTS

Multiple sclerosis patients showed significantly higher serum brain-derived neurotrophic factor levels than healthy controls and patients with other neurological diseases. Multiple sclerosis patients with high brain-derived neurotrophic factor levels were younger, and showed fewer relapse numbers than those with low brain-derived neurotrophic factor levels. Brain-derived neurotrophic factor production by T cells increased with age in healthy controls, but not in multiple sclerosis patients. Interferon beta induced a significant increase in serum brain-derived neurotrophic factor levels. Brain-derived neurotrophic factor production from T cells and TrkB expression levels in peripheral blood mononuclear cells were significantly enhanced in interferon beta-treated multiple sclerosis patients compared with untreated ones.

CONCLUSIONS

A high brain-derived neurotrophic factor level is related to early mild disease in young multiple sclerosis patients. Interferon beta potentiates brain-derived neurotrophic factor production and brain-derived neurotrophic factor receptor expression in peripheral blood mononuclear cells, which may act beneficially.

Для цитирования: Yoshimura Satoshi, Ochi Hirofumi, Isobe Noriko, Matsushita Takuya, Motomura Kyoko, Matsuoka Takeshi, Minohara Motozumi, Kira Jun-ichi. Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis.. Multiple sclerosis (Houndmills, Basingstoke, England). 2010. DOI: 10.1177/1352458510375706.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.